Catalyst Pharmaceuticals Inc CPRX

NAS: CPRX | ISIN: US14888U1016 14/07/2025

21,62 USD (-0,87%)

(-0,87%) 14/07/2025

Grafiek Catalyst Pharmaceuticals Inc

Grafiek Catalyst Pharmaceuticals Inc

1 dag1d -0,87%
1 week1w 3,20%
1 maand1m -8,66%
3 maanden3m -5,18%
6 maanden6m -2,57%
1 jaar1j 29,07%
5 jaar5j 335,89%

Catalyst Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

13 september 2022 · Catalyst Pharmaceuticals Set to Join S&P SmallCap 600 · Persbericht

15 maart 2021 · Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update · Persbericht

4 maart 2021 · Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 16th, 2021 · Persbericht

22 februari 2021 · Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2021 · Persbericht

6 januari 2021 · Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update · Persbericht

Profiel Catalyst Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: catalystpharma.com

Hoofdzetel: Coral Gables, Florida Verenigde Staten

CEO: Patrick McEnany

Werknemers: 71

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe